CADTH is committed to supporting Canada’s health care decision-makers through this challenging and uncertain time.
For evidence, tools, and resources related to COVID-19, visit our COVID-19 Evidence Portal.


Begin main content

Screening for Shiga-toxigenic Escherichia coli in Clinical Fecal Samples: Diagnostic Accuracy, Clinical Utility, and Guidelines

Last updated: May 6, 2015
Project Number: RA0751-000
Product Line: Rapid Response
Research Type: Other Diagnostics
Report Type: Reference List
Result type: Report


  1. What is the diagnostic accuracy of different methods for the identification of shiga-toxigenic E. coli (STEC) compared with reference testing?
  2. What is the clinical utility of shiga-toxigenic E. coli testing in patients with diarrhea of unknown etiology?
  3. What are the evidence-based guidelines regarding shiga-toxigenic E. coli screening from fecal samples in primary care settings?

Key Message

One health technology assessment was identified regarding STEC screening from fecal samples in primary care settings.